Clinical Trials Browser

Phase 1 × Limited Stage Small Cell Lung Cancer × Clear all

NCT05942508 2023-07-12

A Phase Ib Study of TQB2450 Combined With Anlotinib in Patients With Limited Stage Small Cell Lung Cancer After First-line Radiotherapy and Chemotherapy

Phase 1 Unknown

Limited Stage Small Cell Lung Cancer